AnnS.CollinsMD

Obstetrics & Gynecology • Raleigh, NC

Women's Health Alliance, PA pka Centre Ob/Gyn

Join to view full profile

Dr. Collins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Collins' full profile

Already have an account?

Office
4414 Lake Boone Trl
Ste 205
Raleigh, NC 27607
Phone+1 919-788-4444

Education & Training

Vanderbilt University Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
Duke University School of MedicineClass of 1991

Certifications & Licensure

NC State Medical License 1995 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2013-2016
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis Start of enrollment: 2022 May 01
Completed
Phase 3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause Start of enrollment: 2021 Aug 27
Completed
Phase 3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause Start of enrollment: 2021 Aug 27
Completed
Phase 3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) Start of enrollment: 2021 Oct 29
Completed
Phase 3
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy Start of enrollment: 2021 Mar 18
Active, not recruiting
Phase 3
Join now to see all

Committees

member, Johnston Health Board of Directors 2021 - Present
member, chairperson, UNC Rex Board of Directors 2016 - Present

Research History

principal investigator--UWHNC Research2022 - Present
Sub-I UWHNC research2014 - Present

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow